FeaturesSignalPricingFounders
Log inGet started free
BA

Brent Ahrens

Venture CapitalActive

General Partner at Canaan Partners

Menlo Park, United StatesFounded 2008canaan.com/team/brent-ahrens
16
Investments
0
Exits
—
AUM
0.0%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Brent Ahrens.

Get started free

Investment Thesis & Strategy

Canaan Partners invests in various stages of companies within the health and hospital services, health IT, and pharmaceutical industries. They seek to partner with innovative companies that are disrupting the healthcare landscape.

Investment Activity

Deals per year over the last 13 years

2
2008
1
2009
3
2010
0
2011
0
2012
1
2013
0
2014
1
2015
1
2016
0
2017
1
2018
0
2019
1
2020

Portfolio Companies

Selected investments from their portfolio of 16 companies

M
Minimally invasive devices
Healthcare · Seed, 0
Active
M
Mantra Health
Healthcare · Series A, 2020
Active
G
Grey Wolf Therapeutics
Biotech · Series A, 2018
Active
I
Iterum Therapeutics
Biotech · Series B, 2016
Active
U
Unchained Labs
Biotech · Series C+, 2015
Active
C
Coapt Systems
Healthcare · Seed, 2013
Active
S
Semnur Pharmaceuticals
Biotech · Seed, 2010
Active
S
Spinifex Pharmaceuticals
Biotech · Seed, 2010
Active
R
Relievant Medsystems
Healthcare · Series C+, 2010
Active
A
AtheroMed
Healthcare · Seed, 2009
Active
K
Kalidex Pharmaceuticals
Biotech · Seed, 2008
Active
E
Elevation Pharmaceuticals
Biotech · Seed, 2008
Active

Frequently Asked Questions

Brent Ahrens focuses on Series B, Series A stage investments.

Related Investors

Threshold

Menlo Park, United States · 841 deals

Lightspeed Venture Partners

Menlo Park, United States · 839 deals

Andreessen Horowitz

Menlo Park, United States · 826 deals

Khosla Ventures

Menlo Park, United States · 769 deals

Greylock

Menlo Park, United States · 720 deals

GGV Capital

Menlo Park, United States · 625 deals